Prostate metastasis refers to secondary tumor involvement of the prostate from other primary malignancies and is extremely rare. Secondary involvement of the prostate occurs through three mechanisms: direct invasion (bladder or rectal carcinoma invading the prostate — most common mechanism), hematogenous spread (melanoma, lung cancer — rare), and lymphatic spread. Metastatic tumor is incidentally detected in 0.5-1% of all prostate biopsies. The most common primary source is bladder carcinoma (60-70%), followed by rectal carcinoma and melanoma. Clinically, it can be confused with BPH or prostatitis; however, PSA level is typically normal (as it does not originate from glandular epithelium). On mpMRI, a mass extending from the prostatic capsule into the parenchyma or diffuse infiltration is seen; in the direct invasion form, tumor tissue showing continuity from the bladder or rectal wall is observed.
Age Range
50-80
Peak Age
65
Gender
Male predominant
Prevalence
Rare
Prostate metastasis develops through three different spread mechanisms. The most common mechanism, direct invasion, occurs due to anatomical proximity: bladder carcinoma (especially trigone and bladder base tumors) invades the posterior prostate by traversing Denonvilliers' fascia; rectal carcinoma involves the prostate posteriorly from the anterior rectal wall. This direct invasion appears on MRI as disruption of capsular continuity and uninterrupted tumor tissue between the extraprostatic component and the prostatic component. In hematogenous spread (melanoma, lung carcinoma), tumor emboli settle within the prostatic stroma via the prostatic arterial/venous plexus and form focal masses. These hematogenous metastases typically present as multiple focal lesions in deep portions of the prostatic parenchyma. In melanoma metastases, melanin pigment creates characteristic T1 hyperintensity on MRI due to its T1-shortening effect. In lymphatic spread, retrograde lymphatic flow through pelvic lymph nodes reaches the prostatic lymphatic network.
Uninterrupted tumor tissue extending from the bladder base or rectal wall through the prostate capsule into the prostate parenchyma — this 'outside-in invasion' pattern is the most reliable radiological indicator of secondary tumor involvement of the prostate. In primary prostate adenocarcinoma, invasion occurs 'inside-out' (from prostate parenchyma to capsule); this reverse invasion pattern strongly suggests metastatic/invasive origin.
Focal disruption of the prostate capsule with a hypointense mass extending from the capsule into the prostate parenchyma on T2-weighted images. In the direct invasion form, uninterrupted tumor tissue is seen from the bladder base or rectal wall to the prostatic capsule. The tumor-prostate boundary may be irregular and spiculated. Zonal anatomy is disrupted in the invaded area. In hematogenous metastases, focal, well or poorly circumscribed T2 hypointense mass(es) are seen within the prostatic parenchyma.
Report Sentence
A T2 hypointense mass extending from the disrupted prostate capsule into the prostate parenchyma is observed; direct invasion/metastasis should be considered in conjunction with known primary malignancy history.
Focal or multifocal diffusion restriction on DWI. Low ADC values on ADC map reflect tumor cellularity. In the direct invasion form, diffusion restriction is prominent in the area extending from the prostate capsule into the parenchyma. In hematogenous metastases, multiple small focal areas of diffusion restriction may be seen. In PI-RADS v2.1 context, these findings may be assessed as PI-RADS 4-5, but the invasion pattern originating from outside the capsule differs from typical adenocarcinoma.
Report Sentence
Focal/multifocal diffusion restriction is observed in the prostate, and metastatic involvement should be considered with the invasion pattern originating from outside the capsule.
Characteristic hyperintensity on T1-weighted images in melanoma metastases. This finding is due to the paramagnetic effect of melanin pigment and is specific to melanoma among prostate metastases. This finding may be absent in amelanotic melanoma metastases. T1 hyperintensity can also be confused with hemorrhage, but melanoma history is distinguishing.
Report Sentence
A focal lesion hyperintense on T1-weighted images is observed in the prostate, consistent with melanoma metastasis due to melanin content in conjunction with known melanoma history.
Heterogeneously enhancing mass showing continuity from the bladder base or rectal wall to the prostate on contrast-enhanced CT. The periprostatic fat plane is obliterated and organ boundaries are indistinguishable. In tumors of bladder origin, bladder wall thickening and intraluminal component accompany; in tumors of rectal origin, a rectal mass is present. Pelvic and retroperitoneal lymphadenopathy may be seen.
Report Sentence
A heterogeneously enhancing mass showing continuity from the bladder base/rectal wall to the prostate is observed with obliteration of the periprostatic fat plane — consistent with direct prostate invasion by adjacent organ carcinoma.
Heterogeneously enhancing mass within the prostate on dynamic contrast-enhanced MRI. The enhancement pattern reflects the characteristics of the primary tumor: urothelial carcinoma and rectal adenocarcinoma typically show progressive heterogeneous enhancement; melanoma metastases may demonstrate intense and early enhancement. Non-enhancing areas represent necrosis or cystic degeneration. Contrast-enhanced series best demonstrate tumor-organ continuity in the direct invasion pattern.
Report Sentence
A heterogeneously enhancing mass is observed in the prostate parenchyma showing continuity from the adjacent organ tumor — consistent with direct invasion/metastasis.
Focal prostate lesion showing prominent enhancement in the arterial phase in hematogenous metastases from hypervascular primary tumors (melanoma, renal cell carcinoma). This pattern is rare but diagnostic in conjunction with known hypervascular malignancy history. Enlargement of periprostatic vascular structures may accompany.
Report Sentence
A focal lesion with prominent arterial phase enhancement is observed in the prostate, and hematogenous metastasis should be considered in conjunction with known hypervascular malignancy history.
Criteria
Most common form (60-70%). Invasion of the prostate by bladder base/trigone tumor crossing Denonvilliers' fascia. Evaluated in T3b-T4 bladder cancer staging.
Distinct Features
Uninterrupted tumor tissue from bladder wall to prostate. Accompanied by intraluminal bladder mass. Urothelial histology (CK7+, CK20+, GATA3+). PSA negative.
Criteria
Second most common form. Invades the posterior surface of the prostate from the anterior rectal wall through Denonvilliers' fascia. Evaluated in T4 rectal cancer staging.
Distinct Features
Mass on the posterior prostatic surface with continuity from the rectal wall. Rectal mucosal irregularity and mass. Adenocarcinoma histology (CDX2+, CK20+). PSA negative.
Criteria
Rare form. Hematogenous spread from distant primary malignancy to the prostatic vascular plexus. Melanoma, lung, kidney, and GI tumors are the most common sources. Usually in the context of widespread metastatic disease.
Distinct Features
Focal mass(es) within the prostate parenchyma, independent of capsule. T1 hyperintensity in melanoma (melanin). Widespread metastatic disease accompanies. Immunohistochemistry consistent with primary tumor.
Distinguishing Feature
Adenocarcinoma originates from the prostate parenchyma and shows 'inside-out' invasion; metastasis shows 'outside-in' invasion pattern. PSA is elevated in adenocarcinoma; PSA is normal in metastasis. Adenocarcinoma is assessed by focal T2 hypointensity + DWI restriction in PI-RADS v2.1; metastasis is characterized by capsular disruption.
Distinguishing Feature
Lymphoma shows diffuse, homogeneous T2 hypointensity and homogeneous enhancement; metastasis is typically focal, heterogeneous, and associated with capsular disruption. Lymphoma shows intense homogeneous FDG uptake on PET-CT, while solid organ metastases show more heterogeneous uptake.
Distinguishing Feature
Prostatitis typically shows wedge-shaped or segmental T2 hypointensity; periprostatic inflammatory changes, fever, and dysuria accompany. Metastasis is associated with focal mass and capsular disruption with known malignancy history. Response to antibiotic treatment confirms prostatitis.
Urgency
urgentManagement
medicalBiopsy
NeededFollow-up
specialist-referralWhen prostate metastasis is detected, notification to the primary tumor's treatment team and multidisciplinary approach are required. In the direct invasion form, staging is performed according to the primary tumor (bladder T4, rectum T4). Histological confirmation by biopsy (primary tumor confirmation with immunohistochemistry) is required — PSA, GATA3, CDX2, S100/HMB45 (melanoma) panel. Treatment is systemic therapy directed at the primary tumor: chemoradiation or radical cystoprostatectomy for bladder carcinoma, neoadjuvant chemoradiation + surgery for rectal carcinoma. In hematogenous metastases (melanoma etc.), systemic therapy (immunotherapy, targeted therapy) is applied. Prognosis depends on primary tumor type and stage; prostate invasion generally represents advanced-stage disease.
Prostatic metastasis is extremely rare but should be considered in the presence of known malignancy. It most commonly occurs through direct invasion (bladder/rectum) or hematogenous spread (lung, melanoma). Normal PSA helps differentiate from primary adenocarcinoma. Treatment is directed at the primary malignancy.